BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Muzica CM, Stanciu C, Huiban L, Singeap AM, Sfarti C, Zenovia S, Cojocariu C, Trifan A. Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end. World J Gastroenterol 2020; 26(43): 6770-6781 [PMID: 33268960 DOI: 10.3748/wjg.v26.i43.6770]
URL: https://www.wjgnet.com/1948-5182/full/v26/i43/6770.htm
Number Citing Articles
1
Patricia Holanda Almeida, Celso E L Matielo, Lilian A Curvelo, Rodrigo A Rocco, Guilherme Felga, Bianca Della Guardia, Yuri L Boteon. Update on the management and treatment of viral hepatitisWorld Journal of Gastroenterology 2021; 27(23): 3249-3261 doi: 10.3748/wjg.v27.i23.3249
2
Pietro Torre, Andrea Aglitti, Mario Masarone, Marcello Persico. Viral hepatitis: Milestones, unresolved issues, and future goalsWorld Journal of Gastroenterology 2021; 27(28): 4603-4638 doi: 10.3748/wjg.v27.i28.4603
3
Galal Yahya, Nashwa Hashem Mohamed, Jordi Pijuan, Noura M. Seleem, Rasha Mosbah, Steffen Hess, Ahmed A. Abdelmoaty, Rafa Almeer, Mohamed M. Abdel‐Daim, Hamoud Shulaywih Alshaman, Ibrahim Juraiby, Kamel Metwally, Zuzana Storchova. Profiling the physiological pitfalls of anti‐hepatitis C direct‐acting agents in budding yeastMicrobial Biotechnology 2021; 14(5): 2199 doi: 10.1111/1751-7915.13904
4
Moustafa Sarhan, Alaa M. H. El-Bitar, Amaal Mohammadein, Mohammed Elshehaby, Hak Hotta. Virucidal activity of oriental hornet Vespa orientalis venom against hepatitis C virusJournal of Venomous Animals and Toxins including Tropical Diseases 2021; 27 doi: 10.1590/1678-9199-jvatitd-2021-0039
5
Jennifer O. Lam, Leo B. Hurley, Jennifer B. Lai, Varun Saxena, Suk Seo, Scott Chamberland, Charles P. Quesenberry, Jamila H. Champsi, Joanna Ready, Elizabeth Y. Chiao, Julia L. Marcus, Michael J. Silverberg. Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting AntiviralsCancer Epidemiology Biomarkers & Prevention 2021; 30(12): 2188 doi: 10.1158/1055-9965.EPI-21-0742
6
Sarah El-Nakeep. Molecular and genetic markers in hepatocellular carcinoma: <i>In silico </i>analysis to clinical validation (current limitations and future promises)World Journal of Gastrointestinal Pathophysiology 2022; 13(1): 1-14 doi: 10.4291/wjgp.v13.i1.1
7
Cristina Maria Muzica, Carol Stanciu, Cristina Cijevschi-Prelipcean, Irina Girleanu, Laura Huiban, Oana Cristina Petrea, Ana-Maria Singeap, Camelia Cojocariu, Tudor Cuciureanu, Catalin Sfarti, Sebastian Zenovia, Stefan Chriac, Gabriela Stefanescu, Irina Ciortescu, Corina Lupașcu-Ursulescu, Egidia Miftode, Anca Trifan. Long-term Risk of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy in Compensated Liver Cirrhosis Induced by Hepatitis C Virus InfectionHepatitis Monthly 2021; 21(6) doi: 10.5812/hepatmon.115910
8
Ester Badia Aranda, Cristina Fernández Marcos, Aida Puebla Maestu, Visitación Gozalo Marín, Raquel Vinuesa Campo, Sara Calvo Simal, Judith Gómez Camarero. Evolución de los pacientes con infección crónica por hepatitis C con fibrosis avanzada o cirrosis curados con antivirales de acción directa. Seguimiento a largo plazoGastroenterología y Hepatología 2022;  doi: 10.1016/j.gastrohep.2022.02.002
9
Saleh A. Alqahtani, Massimo Colombo. Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular CarcinomaCells 2021; 10(11): 3091 doi: 10.3390/cells10113091
10
Nancy Abdel Fattah Ahmed, Ahmed Shawky Hassan Ali, Rizk Ahmed El Baz, Islam Abd El-Hamid El-Zayyadi. IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antiviralsEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00102-x
11
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma DevelopmentCancers 2021; 13(10): 2485 doi: 10.3390/cancers13102485
12
Farina M Hanif, Zain Majid, Nasir Hassan Luck, Abbas Ali Tasneem, Syed Muddasir Laeeq, Muhammed Mubarak. Revolution in the diagnosis and management of hepatitis C virus infection in current eraWorld Journal of Hepatology 2022; 14(4): 647-669 doi: 10.4254/wjh.v14.i4.647
13
Tiffany Khoo, Danielle Lam, John K Olynyk. Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver diseaseWorld Journal of Gastroenterology 2021; 27(29): 4831-4845 doi: 10.3748/wjg.v27.i29.4831
14
Hideki Hagiwara, Yoshiki Ito, Takashi Ohta, Yasutoshi Nozaki, Takayuki Iwamoto, Atsushi Hosui, Naoki Hiramatsu, Yuki Tahata, Ryotaro Sakamori, Hayato Hikita, Norio Hayashi. Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct‐acting antiviral agents among the working population in JapanJGH Open 2022;  doi: 10.1002/jgh3.12745
15
María B Pisano, Cecilia G Giadans, Diego M Flichman, Viviana E Ré, María V Preciado, Pamela Valva. Viral hepatitis update: Progress and perspectives World Journal of Gastroenterology 2021; 27(26): 4018-4044 doi: 10.3748/wjg.v27.i26.4018
16
Sung-Shuo Kao, Chia-Jung Li, James Cheng-Chung Wei, Cheng-Li Lin, Renin Chang, Yao-Min Hung. Human Papillomavirus Infection Is Associated with Decreased Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients: Taiwan Nationwide Matched Cohort StudyCancers 2022; 14(5): 1289 doi: 10.3390/cancers14051289